Evidence Hub

Management of Mycotic Abdominal Aortic Aneurysm Caused by Levofloxacin- and Ampicillin-Resistant Campylobacter fetus With Synthetic Vascular Graft Replacement Surgery and Long-Term Minocycline Therapy

Makino J, Nakamura FU, Shiraishi M, Okada K, Goto T

Cureus, 2025

Abstract

Mycotic aortic aneurysms caused by Campylobacter fetus (C. fetus) are rare, and the optimal regimens and duration of antimicrobial therapy remain unclear. We present a case of a man in his 70s with hypertension and chronic heavy alcohol consumption who presented with an eight-day history of persistent fever. Contrast-enhanced computed tomography of the abdomen and pelvis revealed a mycotic infrarenal aortic aneurysm. Empiric ceftriaxone and vancomycin were switched to minocycline after cultures identified levofloxacin- and ampicillin-resistant, but minocycline-susceptible C. fetus. The patient underwent synthetic graft replacement surgery on day 8 and completed 16 weeks of postoperative minocycline, achieving full recovery and showing no recurrence at a three-year follow-up. This case highlights the importance of early surgical intervention combined with long-term, targeted antimicrobial therapy for managing C. fetus-related mycotic aneurysms.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free